Interestingly, opposite results published in the study analyzed again pediatric FDRs with autoantibodies, which had higher levels of immune regulatory T cells defined as CD4+CD25+HLADR- and CD4+ CD25+CD69-, implying intensification of immune regulatory response during preclinical stages in T1D [5]. Here, CD4 is linked to type 1 diabetes mellitus.